Itolizumab, a monoclonal antibody developed by the Center of Molecular Immunology (CIM) in collaboration with Biocon, India's largest pharmaceutical company,…
After 25 long years of studies and innumerable clinical trials which took place in Canada, the United Kingdom, Malaysia, China…
Established in 1991, the Center of Molecular Immunology (Centro de Inmunologia Molecular) (CIM) situated in Playa, west of Havana, is…